Niva Bupa's Bold Growth: Aiming Beyond Industry Standards

Standalone health insurer Niva Bupa anticipates exceeding a 15% growth rate in premium collections, surpassing industry averages. The company experienced a 21% increase in gross written premium to Rs 4,683 crore. With a strong solvency and robust profitability, Niva Bupa is well-positioned in the health insurance market.

Niva Bupa, a notable standalone health insurer, is gearing up to surpass the industry standard of 15% growth in premium collections by the end of the current financial year.

In the first three quarters of FY25, the company's gross written premium escalated by 21% to Rs 4,683 crore, with a threefold rise in profit after tax reaching Rs 13.2 crore during Q3.

Krishnan Ramachandran, MD and CEO, emphasized the company's strong solvency ratio, now at 3.03, and increasing retail market share as key factors positioning Niva Bupa to seize opportunities within the health insurance domain.

(With inputs from agencies.)